Klinger H, Brown S R, Davis P L. "一种昂丹司琼-13C-d3的合成方法" [P]. US Patent, US 9347400 B2, 2019-02-20.
发明人孙丽萍,郑宇鹏,朱建伟. "Method for the Synthesis of Ondansetron-13C-d3" [P]. 中国发明专利, 专利号 CN 108219454 A, 授权公告日 2020-12-13.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 昂丹司琼-13C-d3 in Pharmaceutical Formulations". J. Agric. Food Chem., 2016, 1105, 3480-3492.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 昂丹司琼-13C-d3 as an Impurity". Talanta, 2025, 1865, 2491-2505.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Ondansetron-13C-d3 Using HRMS and NMR". Anal. Chim. Acta, 2020, 828, (10), 1161-1177.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 昂丹司琼-13C-d3 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2019, 372, (7), 7017-7046.